Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial.
暂无分享,去创建一个
E. Antman | R. Giugliano | E. Braunwald | M. Mercuri | F. Nordio | C. Ruff | I. Cavallari | H. Lanz | Naveen Deenadayalu | M. Shi | H. Rutman
[1] D. Witt,et al. Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding , 2015, Thrombosis and Haemostasis.
[2] Michael J Pencina,et al. Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation , 2017, JAMA.
[3] M. Aguilar,et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.
[4] E. Antman,et al. Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial. , 2016, The American journal of medicine.
[5] L. Køber,et al. Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation. , 2012, European heart journal.
[6] D. Xavier,et al. Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. , 2015, American heart journal.
[7] V. Chair,et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.
[8] A. Haeberli,et al. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence , 1996, British journal of haematology.
[9] J. Harenberg,et al. Plasma hypercoagulability after termination of oral anticoagulants. , 1983, Thrombosis research.
[10] J. Broderick,et al. Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence , 2011, Stroke.
[11] Zaid Alirhayim,et al. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. , 2014, The American journal of cardiology.
[12] L. Poller,et al. EVIDENCE FOR "REBOUND" HYPERCOAGULABILITY AFTER STOPPING ANTICOAGULANTS. , 1964, Lancet.
[13] D. Singer,et al. Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation , 2010, Circulation. Cardiovascular quality and outcomes.
[14] E. Antman,et al. Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.
[15] C. Legnani,et al. Activation of Blood Coagulation after Abrupt or Stepwise Withdrawal of Oral Anticoagulants - A Prospective Study , 1994, Thrombosis and Haemostasis.
[16] Leon Poller,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[17] E. Antman,et al. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). , 2010, American heart journal.
[18] G. Breithardt,et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.
[19] A. Laupacis,et al. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis , 2006, BMJ : British Medical Journal.
[20] Apixaban versus Warfarin in Patients with Atrial Fibrillation , 2012 .